NEW YORK, Feb. 29, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today its financial results for the fourth quarter and full year ending December 31, 2011, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.
